Pharma Policy
- All
- News
- Videos
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Probe Agency Attaches Assets Over Rs 115 Crore Of 2 Approvers In Delhi Liquor Policy Case
The Enforcement Directorate (ED) has attached assets worth more than Rs 115 crore of two of its approvers -- TDP's Lok Sabha poll candidate Magunta Sreenivasulu Reddy's businessman son Raghav Magunta and Aurobindo Pharma promoter Sarath Chandra Reddy
-
K Kavitha "Threatened" Pharma Firm Boss To Pay Rs 25 Crore To AAP: CBI To Court
CBI told a special court here that BRS leader K Kavitha allegedly "threatened" Aurobindo Pharma promoter Sharath Chandra Reddy to pay an amount of Rs 25 crore to the AAP for the five retail zones allotted to his firm under the Delhi excise policy.
-
This Firm With Liquor Policy Case Link Bought Rs 52 Crore Electoral Bonds
Aurobindo Pharma, in total, bought electoral bonds worth ₹52 crore, more than half of which was given to the ruling Bharatiya Janata Party (BJP).
-
In Delhi Liquor Policy Case, Boss Of Hyderabad Pharma Firm Is Arrested
A top official of a pharma company has been arrested by the Enforcement Directorate in connection with its money laundering probe into alleged irregularities in the now-scrapped Delhi excise policy.
-
Amid Caution, These Stocks Lose Upto 8% In Run Up To RBI Policy
Natco Pharma, Vakrangee, Redington, NTPC and HCL Technologies posted heavy losses on Wednesday.
-
Allocate More Funds, Increase Expenditure, Say Health Experts
Health experts have pitched for more fund allocation in sectors such as family planning and non-communicable diseases.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
PM Narendra Modi Hints At Rules For Doctors To Prescribe Generic Drugs
Prime Minister Narendra Modi today indicated that his government may bring in a legal framework under which doctors will have to prescribe generic medicines, which are cheaper than equivalent branded drugs, to patients. PM Modi said his government brought in a health policy after 15 years and capped the prices of medicines and stents, which has ang...
-
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
With spiralling costs of medicines becoming a major concern for the common man, the government now plans to bring down the prices of 108 drugs.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Probe Agency Attaches Assets Over Rs 115 Crore Of 2 Approvers In Delhi Liquor Policy Case
The Enforcement Directorate (ED) has attached assets worth more than Rs 115 crore of two of its approvers -- TDP's Lok Sabha poll candidate Magunta Sreenivasulu Reddy's businessman son Raghav Magunta and Aurobindo Pharma promoter Sarath Chandra Reddy
-
K Kavitha "Threatened" Pharma Firm Boss To Pay Rs 25 Crore To AAP: CBI To Court
CBI told a special court here that BRS leader K Kavitha allegedly "threatened" Aurobindo Pharma promoter Sharath Chandra Reddy to pay an amount of Rs 25 crore to the AAP for the five retail zones allotted to his firm under the Delhi excise policy.
-
This Firm With Liquor Policy Case Link Bought Rs 52 Crore Electoral Bonds
Aurobindo Pharma, in total, bought electoral bonds worth ₹52 crore, more than half of which was given to the ruling Bharatiya Janata Party (BJP).
-
In Delhi Liquor Policy Case, Boss Of Hyderabad Pharma Firm Is Arrested
A top official of a pharma company has been arrested by the Enforcement Directorate in connection with its money laundering probe into alleged irregularities in the now-scrapped Delhi excise policy.
-
Amid Caution, These Stocks Lose Upto 8% In Run Up To RBI Policy
Natco Pharma, Vakrangee, Redington, NTPC and HCL Technologies posted heavy losses on Wednesday.
-
Allocate More Funds, Increase Expenditure, Say Health Experts
Health experts have pitched for more fund allocation in sectors such as family planning and non-communicable diseases.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
PM Narendra Modi Hints At Rules For Doctors To Prescribe Generic Drugs
Prime Minister Narendra Modi today indicated that his government may bring in a legal framework under which doctors will have to prescribe generic medicines, which are cheaper than equivalent branded drugs, to patients. PM Modi said his government brought in a health policy after 15 years and capped the prices of medicines and stents, which has ang...
-
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
With spiralling costs of medicines becoming a major concern for the common man, the government now plans to bring down the prices of 108 drugs.
